Klompas Neil A has filed 9 insider transactions across 2 companies since January 2023.
Most recent transaction: a grant/award of 1750 shares of InMed Pharmaceuticals Inc. ($INM) on December 19, 2025.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 19, 2025 | InMed Pharmaceuticals Inc. | $INM | Klompas Neil A | Director | A | Employee Stock Option (Right to Buy) | 1750 | $0.00 | 5,250.0000 | 3,954,549 | 50.00% | 0.04% |
| Oct. 17, 2025 | InMed Pharmaceuticals Inc. | $INM | Klompas Neil A | Director | A | Employee Stock Option (Right to Buy) | 3500 | $0.00 | 3,500.0000 | 3,954,549 | 9999.99% | 0.09% |
| March 10, 2023 | Zymeworks Inc. | $ZYME | Klompas Neil A | President & COO | M | Restricted Stock Unit | 2708 | $0.00 | 2,709.0000 | 65,249,184 | 49.99% | 0.00% |
| March 10, 2023 | Zymeworks Inc. | $ZYME | Klompas Neil A | President & COO | S | Common Stock | 2977 | $7.83 | 17,732.0000 | 65,249,184 | 14.38% | 0.00% |
| March 10, 2023 | Zymeworks Inc. | $ZYME | Klompas Neil A | President & COO | M | Restricted Stock Unit | 2500 | $0.00 | 0.0000 | 65,249,184 | 100.00% | 0.00% |
| March 10, 2023 | Zymeworks Inc. | $ZYME | Klompas Neil A | President & COO | M | Common Stock | 2708 | $0.00 | 20,709.0000 | 65,249,184 | 15.04% | 0.00% |
| March 10, 2023 | Zymeworks Inc. | $ZYME | Klompas Neil A | President & COO | M | Common Stock | 2500 | $0.00 | 18,001.0000 | 65,249,184 | 16.13% | 0.00% |
| Jan. 5, 2023 | Zymeworks Inc. | $ZYME | Klompas Neil A | President & COO | A | Restricted Stock Unit | 58500 | $0.00 | 58,500.0000 | 65,249,184 | 9999.99% | 0.09% |
| Jan. 5, 2023 | Zymeworks Inc. | $ZYME | Klompas Neil A | President & COO | A | Stock Option (Right to Buy) | 87500 | $0.00 | 87,500.0000 | 65,249,184 | 9999.99% | 0.13% |